Avid Bioservices unveils mammalian cell facilities expansion 06-Apr-2023 By Rachel Arthur Avid Bioservices, a dedicated biologics CDMO in the US, has completed two expansions within the company’s mammalian cell facilities
Lonza invests in Singapore to support growth in mammalian biologics 11-Oct-2021 By Jane Byrne Lonza is investing to expand mammalian development services at its Singapore facility; the move will bring additional capacity for cell culture, purification, and analytical services for mammalian biologics.
